Dec 21, 2022

Innovative Health Initiative launches new calls

The Innovative Health Initiative (IHI) is a newly established public-private partnership between the European Commission and industry associations in the healthcare sector within the framework of Horizon Europe. It focuses on the promotion of health research and innovation. IHI follows the Innovative Medicines Initiative 2 (IMI2), but its scope is much broader. Industry associations participating in IHI include EFPIA (pharmaceutical companies), COCIR (imaging, radiotherapy, ICT and electromedicine companies), MedTechEurope (medical technology companies), EuropaBio (biotechnology companies) and VaccinesEurope (vaccine companies).

IHI has now launched a third call for proposal and announced a fourth call as well:

IHI – call 3 (single stage) with deadline 15.03.2023:

Topic 1: Screening platform and biomarkers for prediction and prevention of diseases of unmet public health need

Topic 2: Patient-generated evidence to improve outcomes, support decision making, and accelerate innovation

Topic 3: Combining hospital interventional approaches to improve patient outcomes and increase hospital efficiency

Topic 4: Strengthening the European translational research ecosystem for advanced therapy medicinal products (ATMPs) for rare diseases

Topic 5: Digital health technologies for the prevention and personalised management of mental disorders and their long-term health consequences

IHI – call 4 (two stage) updated draft version:

Topic 1: Expanding translational knowledge in minipigs: a path to reduce and replace non-human primates in non-clinical safety assessment

Topic 2: Patient-centric blood sample collection to enable decentralised clinical trials and improve access to healthcare

On January 18/19, 2023, IHI invites you to an online information event about the 4^th call for proposals. The agenda includes the presentation of the calls for proposals but also time for networking and partner identification. Participation in the event is free of charge. Registration is now available.

Further information: